NM_152709.5:c.230C>T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_152709.5(STOX1):c.230C>T(p.Pro77Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152709.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 9AN: 55660Hom.: 0 Cov.: 7 FAILED QC
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000641 AC: 1AN: 155904Hom.: 0 Cov.: 4 AF XY: 0.0000134 AC XY: 1AN XY: 74890
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000162 AC: 9AN: 55660Hom.: 0 Cov.: 7 AF XY: 0.000182 AC XY: 5AN XY: 27502
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.230C>T (p.P77L) alteration is located in exon 1 (coding exon 1) of the STOX1 gene. This alteration results from a C to T substitution at nucleotide position 230, causing the proline (P) at amino acid position 77 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at